Published in PLoS One on April 04, 2012
Expression and Purification of Human Membrane Progestin Receptor α (mPRα). PLoS One (2015) 0.75
Nucleophosmin/B23 is a negative regulator of estrogen receptor α expression via AP2γ in endometrial cancer cells. Oncotarget (2016) 0.75
Progesterone suppresses triple-negative breast cancer growth and metastasis to the brain via membrane progesterone receptor α. Int J Mol Med (2017) 0.75
Molecular portraits of human breast tumours. Nature (2000) 94.14
The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell (2008) 46.08
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol (2006) 25.12
American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J Clin Oncol (2007) 14.29
Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer. J Natl Cancer Inst (2009) 10.91
Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS One (2008) 8.97
Caveolin-1 in oncogenic transformation, cancer, and metastasis. Am J Physiol Cell Physiol (2005) 3.20
Sex hormones and the immune response in humans. Hum Reprod Update (2005) 3.13
Multiple actions of steroid hormones--a focus on rapid, nongenomic effects. Pharmacol Rev (2000) 2.94
Cloning, expression, and characterization of a membrane progestin receptor and evidence it is an intermediary in meiotic maturation of fish oocytes. Proc Natl Acad Sci U S A (2003) 2.82
Physiological action of progesterone in target tissues. Endocr Rev (1997) 2.73
Caveolae as organizers of pharmacologically relevant signal transduction molecules. Annu Rev Pharmacol Toxicol (2008) 2.57
Nongenomic actions of steroid hormones. Nat Rev Mol Cell Biol (2003) 2.54
Current and emerging biomarkers in breast cancer: prognosis and prediction. Endocr Relat Cancer (2010) 2.35
Caveolin-1 expression is associated with a basal-like phenotype in sporadic and hereditary breast cancer. Breast Cancer Res Treat (2006) 2.10
Lapatinib: a dual inhibitor of human epidermal growth factor receptor tyrosine kinases. Clin Ther (2008) 1.90
Histopathologic variables predict Oncotype DX recurrence score. Mod Pathol (2008) 1.72
Characteristics of membrane progestin receptor alpha (mPRalpha) and progesterone membrane receptor component 1 (PGMRC1) and their roles in mediating rapid progestin actions. Front Neuroendocrinol (2008) 1.60
Caveolin 1 and Caveolin 2 are associated with breast cancer basal-like and triple-negative immunophenotype. Br J Cancer (2008) 1.55
Progesterone signaling in human myometrium through two novel membrane G protein-coupled receptors: potential role in functional progesterone withdrawal at term. Mol Endocrinol (2006) 1.39
Hypothesis: Progesterone primes breast cancer cells for cross-talk with proliferative or antiproliferative signals. Mol Endocrinol (1999) 1.34
Non-genomic progesterone actions in female reproduction. Hum Reprod Update (2008) 1.31
Progesterone receptor A (PRA) and PRB-independent effects of progesterone on gonadotropin-releasing hormone release. Endocrinology (2009) 1.31
Clinical and pathologic aspects of basal-like breast cancers. Nat Clin Pract Oncol (2008) 1.28
Classic and non-classic progesterone receptors are both expressed in human spermatozoa. Horm Metab Res (2005) 1.08
Progesterone reverses the mesenchymal phenotypes of basal phenotype breast cancer cells via a membrane progesterone receptor mediated pathway. Breast Cancer Res (2010) 1.03
Anti-EGFR Therapy: Mechanism and Advances in Clinical Efficacy in Breast Cancer. J Oncol (2009) 1.02
Identification of membrane progestin receptors in human breast cancer cell lines and biopsies and their potential involvement in breast cancer. Steroids (2006) 1.01
Scoring of p53, VEGF, Bcl-2 and APAF-1 immunohistochemistry and interobserver reliability in colorectal cancer. Mod Pathol (2006) 1.01
Androgen receptors are frequently expressed in mammary and extramammary Paget's disease. Mod Pathol (2005) 0.93
The human kidney is a progesterone-metabolizing and androgen-producing organ. J Clin Endocrinol Metab (2003) 0.91
Targeting epidermal growth factor receptor in solid tumors: critical evaluation of the biological importance of therapeutic monoclonal antibodies. Curr Med Chem (2009) 0.90
Progesterone: the forgotten hormone in men? Aging Male (2004) 0.89
Tissue microarray for routine clinical breast biomarker analysis. The British Columbia Cancer Agency 2008 experience. Am J Clin Pathol (2010) 0.88
Zona pellucida-induced acrosome reaction in human sperm: dependency on activation of pertussis toxin-sensitive G(i) protein and extracellular calcium, and priming effect of progesterone and follicular fluid. Mol Hum Reprod (2002) 0.85
Erythropoietin and its receptor in breast cancer: correlation with steroid receptors and outcome. Cancer Epidemiol Biomarkers Prev (2007) 0.85
Mammaglobin as a potential molecular target for breast cancer drug delivery. Cancer Cell Int (2009) 0.84
Broad tissue expression of membrane progesterone receptor Alpha in normal mice. J Mol Histol (2010) 0.81
The roles of estrogen and progesterone in regulating carbohydrate and fat utilization at rest and during exercise. J Womens Health Gend Based Med (2002) 0.80
Effect of progesterone receptor a predominance on breast cancer cell migration into bone marrow fibroblasts. Breast Cancer Res Treat (2004) 0.78
Just when you thought it was safe to go into the membrane: the growing complexities of extra-nuclear progesterone signaling. Breast Cancer Res (2010) 0.77
Estrogen, progesterone and the gastrointestinal tract. J Reprod Med (2000) 0.77
Identification of functional elements and regulatory circuits by Drosophila modENCODE. Science (2010) 12.39
Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet (2013) 8.24
Prospective Validation of a 21-Gene Expression Assay in Breast Cancer. N Engl J Med (2015) 5.57
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet (2013) 4.35
Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nat Genet (2013) 3.81
Breast cancer. Clinical practice guidelines in oncology. J Natl Compr Canc Netw (2009) 3.17
Integration of quantitative DCE-MRI and ADC mapping to monitor treatment response in human breast cancer: initial results. Magn Reson Imaging (2006) 2.69
Identification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis. Gastroenterology (2012) 2.57
Deep annotation of Drosophila melanogaster microRNAs yields insights into their processing, modification, and emergence. Genome Res (2010) 2.56
Structure and function of archaeal box C/D sRNP core proteins. Nat Struct Biol (2003) 2.55
Consolidation of the cancer genome into domains of repressive chromatin by long-range epigenetic silencing (LRES) reduces transcriptional plasticity. Nat Cell Biol (2010) 2.38
Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers. Am J Hum Genet (2013) 2.24
Short preoperative treatment with erlotinib inhibits tumor cell proliferation in hormone receptor-positive breast cancers. J Clin Oncol (2008) 2.10
Serum ceramides increase the risk of Alzheimer disease: the Women's Health and Aging Study II. Neurology (2012) 1.91
Resistance to Trastuzumab in Breast Cancer. Clin Cancer Res (2009) 1.86
Fine mapping of chromosome 6q23-25 region in familial lung cancer families reveals RGS17 as a likely candidate gene. Clin Cancer Res (2009) 1.83
Multicenter phase II study of neoadjuvant lapatinib and trastuzumab with hormonal therapy and without chemotherapy in patients with human epidermal growth factor receptor 2-overexpressing breast cancer: TBCRC 006. J Clin Oncol (2013) 1.81
Breast cancer, version 3.2013: featured updates to the NCCN guidelines. J Natl Compr Canc Netw (2013) 1.79
Overweight is associated with decreased cognitive functioning among school-age children and adolescents. Obesity (Silver Spring) (2008) 1.71
Evaluation of metformin in early breast cancer: a modification of the traditional paradigm for clinical testing of anti-cancer agents. Breast Cancer Res Treat (2010) 1.65
Breast cancer version 3.2014. J Natl Compr Canc Netw (2014) 1.63
Genetic polymorphisms in the estrogen receptor alpha gene and risk of breast cancer: results from the Shanghai Breast Cancer Study. Cancer Epidemiol Biomarkers Prev (2003) 1.62
Aurora-A/STK15 T+91A is a general low penetrance cancer susceptibility gene: a meta-analysis of multiple cancer types. Carcinogenesis (2005) 1.61
Breast Cancer Version 2.2015. J Natl Compr Canc Netw (2015) 1.59
Dietary intake of PUFAs and colorectal polyp risk. Am J Clin Nutr (2012) 1.51
Identification of markers of taxane sensitivity using proteomic and genomic analyses of breast tumors from patients receiving neoadjuvant paclitaxel and radiation. Clin Cancer Res (2010) 1.43
Invasive breast cancer. J Natl Compr Canc Netw (2011) 1.43
Dietary calcium and magnesium intakes and the risk of type 2 diabetes: the Shanghai Women's Health Study. Am J Clin Nutr (2009) 1.40
Invasive Breast Cancer Version 1.2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw (2016) 1.40
Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1. Am J Hum Genet (2013) 1.39
Neoadjuvant concurrent paclitaxel and radiation in stage II/III breast cancer. Clin Cancer Res (2006) 1.34
MTHFR polymorphisms, dietary folate intake, and breast cancer risk: results from the Shanghai Breast Cancer Study. Cancer Epidemiol Biomarkers Prev (2004) 1.33
Interaction of soy food and tea consumption with CYP19A1 genetic polymorphisms in the development of endometrial cancer. Am J Epidemiol (2007) 1.33
Dietary patterns and breast cancer risk in the shanghai breast cancer study. Cancer Epidemiol Biomarkers Prev (2007) 1.32
Dietary factors and risk of colon cancer in Shanghai, China. Cancer Epidemiol Biomarkers Prev (2003) 1.31
Circulating carotenoids and risk of breast cancer: pooled analysis of eight prospective studies. J Natl Cancer Inst (2012) 1.31
A study of transportability of an existing smoking status detection module across institutions. AMIA Annu Symp Proc (2012) 1.31
Sox7 Is an independent checkpoint for beta-catenin function in prostate and colon epithelial cells. Mol Cancer Res (2008) 1.30
Menstrual and reproductive factors and endometrial cancer risk: Results from a population-based case-control study in urban Shanghai. Int J Cancer (2004) 1.29
Extracting and integrating data from entire electronic health records for detecting colorectal cancer cases. AMIA Annu Symp Proc (2011) 1.29
Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer. Carcinogenesis (2013) 1.28
Metastatic breast cancer, version 1.2012: featured updates to the NCCN guidelines. J Natl Compr Canc Netw (2012) 1.23
Disruption of endothelial peroxisome proliferator-activated receptor-gamma reduces vascular nitric oxide production. Am J Physiol Heart Circ Physiol (2009) 1.22
Functional requirement for symmetric assembly of archaeal box C/D small ribonucleoprotein particles. J Mol Biol (2003) 1.22
Joint effect of estrogen receptor beta sequence variants and endogenous estrogen exposure on breast cancer risk in Chinese women. Cancer Res (2003) 1.19
DCE-MRI analysis methods for predicting the response of breast cancer to neoadjuvant chemotherapy: pilot study findings. Magn Reson Med (2013) 1.19
Soya food intake and risk of endometrial cancer among Chinese women in Shanghai: population based case-control study. BMJ (2004) 1.17
A genome-wide transgenic resource for conditional expression of Drosophila microRNAs. Development (2012) 1.16
Insulin-like growth factors and breast cancer risk in Chinese women. Cancer Epidemiol Biomarkers Prev (2002) 1.16
Glycogen synthase kinase-3β, NF-κB signaling, and tumorigenesis of human osteosarcoma. J Natl Cancer Inst (2012) 1.15
A novel AIF tracking method and comparison of DCE-MRI parameters using individual and population-based AIFs in human breast cancer. Phys Med Biol (2011) 1.15
Circadian clock coordinates cancer cell cycle progression, thymidylate synthase, and 5-fluorouracil therapeutic index. Mol Cancer Ther (2006) 1.15
Soyfood intake and breast cancer survival: a followup of the Shanghai Breast Cancer Study. Breast Cancer Res Treat (2005) 1.14
Renal function, bisphenol A, and alkylphenols: results from the National Health and Nutrition Examination Survey (NHANES 2003-2006). Environ Health Perspect (2010) 1.12
Oxidative stress measured by urine F2-isoprostane level is associated with prostate cancer. J Urol (2011) 1.11
Passive smoking and breast cancer risk among non-smoking Chinese women. Int J Cancer (2004) 1.10
LRRC4 inhibits human glioblastoma cells proliferation, invasion, and proMMP-2 activation by reducing SDF-1 alpha/CXCR4-mediated ERK1/2 and Akt signaling pathways. J Cell Biochem (2008) 1.09
Assessment of daily intake of toxic elements due to consumption of vegetables, fruits, meat, and seafood by inhabitants of Xiamen, China. J Food Sci (2011) 1.08
Genetic polymorphism in the manganese superoxide dismutase gene, antioxidant intake, and breast cancer risk: results from the Shanghai Breast Cancer Study. Breast Cancer Res (2004) 1.07
Genetic polymorphisms in GSTM1, GSTP1, and GSTT1 and the risk for breast cancer: results from the Shanghai Breast Cancer Study and meta-analysis. Cancer Epidemiol Biomarkers Prev (2004) 1.07
Brain structure and cerebrovascular risk in cognitively impaired patients: Shanghai Community Brain Health Initiative-pilot phase. Arch Neurol (2010) 1.06
Correlation of blood sex steroid hormones with body size, body fat distribution, and other known risk factors for breast cancer in post-menopausal Chinese women. Cancer Causes Control (2004) 1.05
Chemical modification of M13 bacteriophage and its application in cancer cell imaging. Bioconjug Chem (2010) 1.05
CT with histopathologic correlation of FDG uptake in a patient with pulmonary granuloma and pleural plaque caused by remote talc pleurodesis. AJR Am J Roentgenol (2004) 1.05
Energy balance and breast cancer risk. Cancer Epidemiol Biomarkers Prev (2005) 1.05
Nutritional factors in relation to endometrial cancer: a report from a population-based case-control study in Shanghai, China. Int J Cancer (2007) 1.05
Chronic inflammation promotes retinoblastoma protein hyperphosphorylation and E2F1 activation. Cancer Res (2005) 1.04
Plasma sex steroid hormones and breast cancer risk in Chinese women. Int J Cancer (2003) 1.03
Progesterone reverses the mesenchymal phenotypes of basal phenotype breast cancer cells via a membrane progesterone receptor mediated pathway. Breast Cancer Res (2010) 1.03
Drinking green tea modestly reduces breast cancer risk. J Nutr (2008) 1.02
Body mass index and colon cancer risk in Chinese people: menopause as an effect modifier. Eur J Cancer (2006) 1.01
Population-based case-control study of CYP11A gene polymorphism and breast cancer risk. Cancer Epidemiol Biomarkers Prev (2004) 1.01
Fruit and vegetable intakes are associated with lower risk of colorectal adenomas. J Nutr (2008) 1.01
A prospective study of dietary polyunsaturated fatty acids and colorectal cancer risk in Chinese women. Cancer Epidemiol Biomarkers Prev (2009) 1.00
Multiparametric magnetic resonance imaging for predicting pathological response after the first cycle of neoadjuvant chemotherapy in breast cancer. Invest Radiol (2015) 0.99
Major metabolite of F2-isoprostane in urine may be a more sensitive biomarker of oxidative stress than isoprostane itself. Am J Clin Nutr (2012) 0.98
Commuting physical activity and risk of colon cancer in Shanghai, China. Am J Epidemiol (2004) 0.98
Expression patterns of the ATM gene in mammary tissues and their associations with breast cancer survival. Cancer (2007) 0.98
Dietary animal-derived iron and fat intake and breast cancer risk in the Shanghai Breast Cancer Study. Breast Cancer Res Treat (2007) 0.98
Allergies and risk of pancreatic cancer: a pooled analysis from the Pancreatic Cancer Case-Control Consortium. Am J Epidemiol (2013) 0.97
Population-based case-control study of AhR (aryl hydrocarbon receptor) and CYP1A2 polymorphisms and breast cancer risk. Pharmacogenet Genomics (2006) 0.97
hSSB1 regulates both the stability and the transcriptional activity of p53. Cell Res (2012) 0.97
Urinary isothiocyanate excretion, brassica consumption, and gene polymorphisms among women living in Shanghai, China. Cancer Epidemiol Biomarkers Prev (2003) 0.97
Interactions of aryloxyphenoxypropionic acids with sensitive and resistant acetyl-coenzyme a carboxylase by homology modeling and molecular dynamic simulations. J Chem Inf Model (2006) 0.97
Analysis of similarity/dissimilarity of protein sequences. Proteins (2008) 0.96
Magnesium, vitamin D status and mortality: results from US National Health and Nutrition Examination Survey (NHANES) 2001 to 2006 and NHANES III. BMC Med (2013) 0.96
Cancer growth and spread are saltatory and phase-locked to the reproductive cycle through mediators of angiogenesis. Mol Cancer Ther (2005) 0.96
PNN-curve: a new 2D graphical representation of DNA sequences and its application. J Theor Biol (2006) 0.95
Two-stage case-control study of common ATM gene variants in relation to breast cancer risk. Breast Cancer Res Treat (2007) 0.94
Identification of the homeobox protein Prx1 (MHox, Prrx-1) as a regulator of osterix expression and mediator of tumor necrosis factor α action in osteoblast differentiation. J Bone Miner Res (2011) 0.93
Urinary polyphenols and breast cancer risk: results from the Shanghai Women's Health Study. Breast Cancer Res Treat (2009) 0.93
Joint effect of insulin-like growth factors and sex steroids on breast cancer risk. Cancer Epidemiol Biomarkers Prev (2003) 0.93
Obesity, age, and oxidative stress in middle-aged and older women. Antioxid Redox Signal (2011) 0.92
Occupations and breast cancer risk among Chinese women in urban Shanghai. Am J Ind Med (2002) 0.92
Physical activity, body size, and estrogen metabolism in women. Cancer Causes Control (2004) 0.92
MTR and MTRR polymorphisms, dietary intake, and breast cancer risk. Cancer Epidemiol Biomarkers Prev (2006) 0.92
Plasma carotenoids, tocopherols, retinol and breast cancer risk: results from the Shanghai Women Health Study (SWHS). Breast Cancer Res Treat (2008) 0.91
Similarity/dissimilarity studies of protein sequences based on a new 2D graphical representation. J Comput Chem (2010) 0.91